2/7
02:07 am
tlx
Telix Pharmaceuticals (NASDAQ:TLX) was downgraded by analysts at
Wall Str
Neutral
Report
Telix Pharmaceuticals (NASDAQ:TLX) was downgraded by analysts at
Wall Str
2/3
04:38 pm
tlx
Telix Full Year Results 2025 Investor Webcast Notification
Low
Report
Telix Full Year Results 2025 Investor Webcast Notification
2/3
04:35 pm
tlx
Telix Full Year Results 2025 Investor Webcast Notification
Low
Report
Telix Full Year Results 2025 Investor Webcast Notification
1/28
06:43 pm
tlx
First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients
Medium
Report
First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients
1/27
08:44 am
tlx
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
1/24
12:30 am
tlx
Telix Pharmaceuticals (NASDAQ:TLX) was upgraded by analysts at
Wall Stree
Low
Report
Telix Pharmaceuticals (NASDAQ:TLX) was upgraded by analysts at
Wall Stree
1/21
08:00 am
tlx
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
1/20
07:00 am
tlx
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
Low
Report
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
1/20
02:16 am
tlx
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
Low
Report
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
1/19
05:15 pm
tlx
Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging
Low
Report
Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging
1/19
08:02 am
tlx
Telix Pharmaceuticals (NASDAQ:TLX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
Low
Report
Telix Pharmaceuticals (NASDAQ:TLX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
1/16
02:21 pm
tlx
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
Low
Report
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
1/16
02:19 pm
tlx
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
Low
Report
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
1/9
03:56 pm
tlx
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX
Low
Report
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX
1/9
03:30 pm
tlx
TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
Low
Report
TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
1/9
11:57 am
tlx
TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights
Neutral
Report
TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights
1/9
10:10 am
tlx
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
Low
Report
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
1/9
09:00 am
tlx
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX
Low
Report
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX
1/9
06:49 am
tlx
TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
Low
Report
TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
1/9
03:38 am
tlx
Here's What Analysts Think About Telix Pharmaceuticals (TLX) [Yahoo! Finance]
Low
Report
Here's What Analysts Think About Telix Pharmaceuticals (TLX) [Yahoo! Finance]
1/8
07:00 pm
tlx
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
Low
Report
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
1/8
05:46 pm
tlx
Telix Pharmaceuticals Ltd. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX
Low
Report
Telix Pharmaceuticals Ltd. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX
1/8
01:21 pm
tlx
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
Low
Report
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
1/8
01:04 pm
tlx
Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Low
Report
Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
1/8
01:00 pm
tlx
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
Low
Report
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman